Market Tracker

04/24 9:39am ET
2.03
Real-Time Quote
 +0.03 / +1.50%
Today’s Change
1.05
Today|||52-Week Range
7.79
-57.17%
Year-to-Date

Today’s Trading

Previous close2.00
Today’s openn.a.
Day’s range-- - --
Volume3,300
Average volume (3 months)6,362,242
Market cap$304.4M
Dividend yield--
Data as of 04/23/2014

Growth & Valuation

Earnings growth (last year)+44.44%
Earnings growth (this year)+14.17%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.64%
P/E ratioNM
Price/Sales474.30
Price/Book4.24

Competitors

 Today’s
change
Today’s
% change
OXFDOxford Immunotec Glo...0.000.00%
VCYTVeracyte Inc0.000.00%
GALTGalectin Therapeutic...0.000.00%
TTHITransition Therapeut...0.000.00%
Data as of 04/23/2014

Financials

Next reporting dateApril 30, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.3M
Annual profit (last year)-$38.4M
Net profit margin-2,991.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts